REFERENCES
- Apple D J, Solomon K D, Tetz M R, et al. Posterior capsule opacification. Surv Ophthalmol. 1992; 37: 73–116
- Schaumberg D A, Dana M R, Christen W G, Glynn R J. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology. 1998; 105: 1213–1221
- Aslam T M, Devlin H, Dhillon B. Use of Nd:YAG laser capsulotomy. Surv Ophthalmol. 2003; 48: 594–611
- Nishi O. Posterior capsule opacification. Part 1: Experimental investigations. J Cataract Refract Surg. 1999; 25: 106–117
- Couderc B C, de Neuville S, Douin-Echinard V, et al. Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification. Curr Eye Res. 1999; 19: 472–482
- Malecaze F, Couderc B, de Neuville S, et al. Adenovirus-mediated suicide gene transduction: Feasibility in lens epithelium and in prevention of posterior capsule opacification in rabbits. Hum Gene Ther. 1999; 10: 2365–2372
- Wang B, Weng J. Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium. Zhonghua Yan Ke Za Zhi. 2002; 38: 618–622
- Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263–267
- Wiznerowicz M, Trono D. Harnessing H IV for therapy, basic research and biotechnology. Trends Biotechnol 2005; 23: 42–47
- Luque F, Oya R, Macias D, Saniger L. Gene therapy for HIV-1 infection: are lethal genes a valuable tool?. Cell Mol Biol (Noisy-le-grand) 2005; 51: 93–101
- Bank A, Dorazio R, Leboulch P. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia. Ann N Y Acad Sci. 2005; 1054: 308–316
- Imren S, Fabry M E, Westerman K A, et al. High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells. J Clin Invest. 2004; 114: 889–891
- Paquin A, Jaalouk D E, Galipeau J. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications. Hum Gene Ther. 2001; 12: 13–23
- Dilber M S, Abedi M R, Christensson B, et al. Gap junctions promote the bystander effect of herpes simplex thymidine kinase in vivo. Cancer Res. 1997; 57: 1523–1528
- Tanaka T, Yamasaki H, Mesnil M. Stimulation of intercellular communication of poor-communicating cells by gap-junction-competent cells enhances the HSV-TK/GCV bystander effect in vitro. Int J Cancer 2001; 91: 538–542
- Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 2000; 60: 3989–3999
- Goldberg G S, Lamper P D, Sheedy D, et al. Direct isolation and analysis of endogenous transjunctional ADP from Cx43-transfected C6 glioma cells. Exp Cell Res. 1998; 239: 82–92
- Carystinos G D, Alacui-Jamali M A, Phipps J, et al. Upregulation of gap junctional intercellular communication and connexion 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with a glutathione depletion and chemosensitivity in neuroblastoma cells. Cancer Chemother Pharmacol. 2001; 47: 126–132